<DOC>
	<DOCNO>NCT02242656</DOCNO>
	<brief_summary>MP-101 evaluate study see safe , tolerable , help people Short Bowel Syndrome . This study also find take MP-101 improve symptom Short Bowel Syndrome reduce number time subject experience bowel movement .</brief_summary>
	<brief_title>A Phase III Study Evaluate Efficacy , Safety , Pharmacokinetics Investigational Product MP-101 Subjects With Short Bowel Syndrome Who Have Had Inadequate Response Anti-Diarrheals</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Opium</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<criteria>1 . Be male female adult , 18 year age old time consent 2 . Have SBS inadequately control current antidiarrheal medication ( e.g. , loperamide diphenoxylate ) , include subject ileostomy , base 7 day prior Day 1 study . Subjects must &gt; 3months post intestinal resection 3 . Have history persistent loose stool 4 week 4 . Be combination Opium Tincture antidiarrheal ( loperamide diphenoxylate ) antidiarrheal agent alone 5 . If currently take Opium Tincture , willing stop continue use Opium Tincture screen visit start study treatment willing stop use antidiarrheal duration study 6 . Be able maintain current diet duration study 7 . Be stable nutritional support ( parenteral oral ) 8 . Males nonpregnant , nonlactating female postmenopausal , naturally surgically sterile , agree use effective contraceptive method throughout course study . Postmenopausal define least 12 month natural spontaneous amenorrhea , least 6 week follow surgical menopause ( bilateral oophorectomy ) 9 . Females childbearing potential must agree use 1 follow acceptable birth control method : 1 . Surgically sterile ( hysterectomy bilateral oophorectomy ) 2 . Surgically sterile ( bilateral tubal ligation surgery least 6 week prior study initiation ) 3 . Intrauterine device ( IUD ) place least 3 month 4 . Abstinence ( sexual intercourse ) 5 . Barrier method ( condom diaphragm ) spermicide least 14 day prior screen study completion 6 . Stable hormonal contraceptive least 3 month prior study study completion 7 . Vasectomized partner 10 . Females childbearing potential must negative serum human chorionic gonadotropin ( hCG ) pregnancy test screen 11 . Be able understand provide sign informed consent 1 . Unable unwilling stop use Opium Tincture antidiarrheal medication screen visit . 2 . Have history active neurological , endocrine , cardiovascular , pulmonary , hematological , immunologic , psychiatric , metabolic disease consider clinically significant , currently control medication , stable deem Investigator 3 . Have clinically significant electrocardiogram ( ECG ) abnormality determine PI vital sign abnormality ( systolic blood pressure &lt; 90 mmHg , diastolic blood pressure &lt; 60 mmHg , heart rate &gt; 100 bpm ) screen 4 . Have clinically significant elevation liver enzyme ( &gt; 3 time upper limit normal ) clinically relevant renal disease , ( creatinine &gt; 1.5 ) clinically significant abnormal laboratory test result find medical screening determine Principal Investigator 5 . Have history major mental illness opinion Investigator may affect ability subject safely participate reliably complete study 6 . Have history alcohol substance abuse within past 2 year . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz . beer , 5.0 oz . wine , 1.5 oz . distilled spirit ) 7 . Have know allergy intolerance Opium Tincture excipients formulation ( alcohol , opium , morphine ) 8 . Is currently take opioid derivative ( Opium Tincture ) medication , opinion investigator , could interfere interpretation study result 9 . Are currently take antibiotic bacterial overgrowth 10 . Have participate another interventional clinical trial within 30 day prior screen exception observational cohort study noninterventional study . 11 . Have know suspected pregnancy , plan pregnancy , lactation 12 . Have plan surgery course study 13 . Have condition Investigator believe would interfere ability provide inform consent comply study instruction , might confound interpretation study result put subject undue risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>SBS</keyword>
	<keyword>Chronic Diarrhea</keyword>
	<keyword>Short Bowel</keyword>
	<keyword>Short Gut</keyword>
	<keyword>Short Gut Syndrome</keyword>
	<keyword>Anti-Diarrheal</keyword>
	<keyword>Opium Tincture</keyword>
	<keyword>loperamide</keyword>
	<keyword>diphenoxylate</keyword>
	<keyword>ileostomy</keyword>
	<keyword>tincture opium</keyword>
	<keyword>DTO</keyword>
	<keyword>codeine</keyword>
	<keyword>morphine</keyword>
	<keyword>opiate</keyword>
</DOC>